Sebastian BUNK
40Patents
5h-index
25Co-inventors
65Inventor score
Filing activity: Feb 28, 2013 → Dec 13, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10590194B2 | T cell receptors and immune therapy using the same | Chemistry; Metallurgy | 10 | Active |
| US10723796B2 | T cell receptors and immune therapy using the same | Chemistry; Metallurgy | 10 | Active |
| US11111294B2 | T cell receptors and immune therapy using the same | Chemistry; Metallurgy | 10 | Active |
| US11072645B2 | T cell receptors with improved pairing | Chemistry; Metallurgy | 8 | Active |
| US10538573B2 | Transfected T-cells and T-cell receptors for use in immunotherapy against cancers | Human Necessities | 6 | Active |
| US11104894B2 | Method for preparing electrocompetent yeast cells, and method for using said cells | Chemistry; Metallurgy | 3 | Active |
| US10683495B2 | Method for preparing electrocompetent yeast cells, and method for using said cells | Chemistry; Metallurgy | 3 | Active |
| US10874731B2 | T cell receptors and immune therapy using the same | Chemistry; Metallurgy | 2 | Active |
| US10889645B2 | Engineered T cell receptors and immune therapy using the same | Chemistry; Metallurgy | 2 | Active |
| US10889629B2 | Transfected T-cells and T-cell receptors for use in immunotherapy against cancers | Chemistry; Metallurgy | 2 | Active |
| US10800832B2 | T cell receptors and immune therapy using the same against prame positive cancers | Chemistry; Metallurgy | 2 | Active |
| US10550182B2 | T cell receptors and immune therapy using the same | Chemistry; Metallurgy | 2 | Active |
| US10526407B2 | T cell receptors and immune therapy using the same | Chemistry; Metallurgy | 2 | Active |
| US11236145B2 | T cell receptors and immune therapy using the same against PRAME positive cancers | Chemistry; Metallurgy | 1 | Active |
| US11111286B2 | T cell receptors and immune therapy using the same against PRAME positive cancers | Chemistry; Metallurgy | 1 | Active |
| US10702609B2 | T cell receptors and immune therapy using the same | Chemistry; Metallurgy | 1 | Active |
| US11840577B2 | Antigen binding proteins specifically binding MAGE-A | Chemistry; Metallurgy | 1 | Active |
| US10537624B2 | Transfected T-cells and T-cell receptors for use in immunotherapy against cancers | Chemistry; Metallurgy | 1 | Active |
| US10626160B2 | Transfected T-cells and T-cell receptors for use in immunotherapy against cancers | Chemistry; Metallurgy | 1 | Active |
| US10527623B2 | T cell receptors and immune therapy using the same | Physics | 1 | Active |
| US10725044B2 | T cell receptors and immune therapy using the same | Physics | 1 | Active |
| US10618956B2 | Engineered T cell receptors and immune therapy using the same | Chemistry; Metallurgy | 1 | Active |
| US8986670B2 | IgG stimulated remyelination of peripheral nerves | Emerging Cross-Sectional Technologies | 0 | Active |
| US12269881B2 | Antigen binding proteins specifically binding MAGE-A | Chemistry; Metallurgy | 0 | Active |
| US11932689B2 | Engineered T cell receptors and immune therapy using the same | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.